These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23127929)

  • 1. [Identity and intestinal pathologies: the Cdx2 homeotic gene].
    Freund JN
    Ann Pathol; 2012 Nov; 32(5 Suppl):S24-7. PubMed ID: 23127929
    [No Abstract]   [Full Text] [Related]  

  • 2. The microenvironment controls CDX2 homeobox gene expression in colorectal cancer cells.
    Benahmed F; Gross I; Guenot D; Jehan F; Martin E; Domon-Dell C; Brabletz T; Kedinger M; Freund JN; Duluc I
    Am J Pathol; 2007 Feb; 170(2):733-44. PubMed ID: 17255339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression.
    Brabletz T; Spaderna S; Kolb J; Hlubek F; Faller G; Bruns CJ; Jung A; Nentwich J; Duluc I; Domon-Dell C; Kirchner T; Freund JN
    Cancer Res; 2004 Oct; 64(19):6973-7. PubMed ID: 15466189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
    Zheng J; Sun X; Wang W; Lu S
    Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines.
    Bai Y; Akiyama Y; Nagasaki H; Yagi OK; Kikuchi Y; Saito N; Takeshita K; Iwai T; Yuasa Y
    Mol Carcinog; 2000 Jul; 28(3):184-8. PubMed ID: 10942535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells.
    Gross I; Duluc I; Benameur T; Calon A; Martin E; Brabletz T; Kedinger M; Domon-Dell C; Freund JN
    Oncogene; 2008 Jan; 27(1):107-15. PubMed ID: 17599044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2.
    Gao N; White P; Kaestner KH
    Dev Cell; 2009 Apr; 16(4):588-99. PubMed ID: 19386267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas.
    Witek ME; Nielsen K; Walters R; Hyslop T; Palazzo J; Schulz S; Waldman SA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8549-56. PubMed ID: 16361536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas.
    Rausa F; Samadani U; Ye H; Lim L; Fletcher CF; Jenkins NA; Copeland NG; Costa RH
    Dev Biol; 1997 Dec; 192(2):228-46. PubMed ID: 9441664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling.
    da Costa LT; He TC; Yu J; Sparks AB; Morin PJ; Polyak K; Laken S; Vogelstein B; Kinzler KW
    Oncogene; 1999 Sep; 18(35):5010-4. PubMed ID: 10490837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation.
    Calon A; Gross I; Lhermitte B; Martin E; Beck F; Duclos B; Kedinger M; Duluc I; Domon-Dell C; Freund JN
    Gut; 2007 Dec; 56(12):1688-95. PubMed ID: 17595234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cdx-1 and Cdx-2 homeobox genes in the intestine.
    Freund JN; Domon-Dell C; Kedinger M; Duluc I
    Biochem Cell Biol; 1998; 76(6):957-69. PubMed ID: 10392709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intestine-specific homeobox gene Cdx2 induces expression of the basic helix-loop-helix transcription factor Math1.
    Mutoh H; Sakamoto H; Hayakawa H; Arao Y; Satoh K; Nokubi M; Sugano K
    Differentiation; 2006 Jul; 74(6):313-21. PubMed ID: 16831200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation.
    Gross I; Lhermitte B; Domon-Dell C; Duluc I; Martin E; Gaiddon C; Kedinger M; Freund JN
    Oncogene; 2005 Dec; 24(54):7955-63. PubMed ID: 16027724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of homeobox genes in gastrointestinal cancer.
    Joo MK; Park JJ; Chun HJ
    World J Gastroenterol; 2016 Oct; 22(37):8247-8256. PubMed ID: 27729732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer.
    Saandi T; Baraille F; Derbal-Wolfrom L; Cattin AL; Benahmed F; Martin E; Cardot P; Duclos B; Ribeiro A; Freund JN; Duluc I
    Oncogene; 2013 Aug; 32(32):3782-8. PubMed ID: 22986531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and β-catenin activity in colon cancer cells.
    Hinkel I; Duluc I; Martin E; Guenot D; Freund JN; Gross I
    Gastroenterology; 2012 Apr; 142(4):875-885.e3. PubMed ID: 22202456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent rearrangements and amplification of the CDX2 homeobox gene in human sporadic colorectal cancers with chromosomal instability.
    Subtil C; Guérin E; Schneider A; Chenard MP; Martin E; Domon-Dell C; Duluc I; Brabletz T; Kedinger M; Duclos B; Gaub MP; Freund JN
    Cancer Lett; 2007 Mar; 247(2):197-203. PubMed ID: 16730885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.